{
  "timestamp": "2026-01-05T07:05:11.131732",
  "agent_id": "medication_management",
  "phase": "complete",
  "input_data": null,
  "prompt": null,
  "llm_response": null,
  "output_data": {
    "clarification_needed": false,
    "clarification_question": null,
    "suggested_answer": null,
    "medications": [
      {
        "name": "Sertraline",
        "generic_name": "Sertraline",
        "brand_name": null,
        "strength": "50 mg",
        "form": "Tablet",
        "route": "Oral",
        "frequency": "Daily",
        "indication": "Major Depressive Disorder",
        "response": "Inadequate/Minimal effect after 4-week trial.",
        "adherence": "Good (Patient states taking 'every day')",
        "side_effects": []
      }
    ],
    "changes_made": [
      {
        "medication": "Sertraline",
        "change_type": "Increase Dose",
        "rationale": "Inadequate clinical response (persistent anhedonia, fatigue, early morning awakening, and depressive ideation) after 4-week trial at 50mg daily. Titration to therapeutic dose of 100mg."
      }
    ],
    "peer_review_finding": {
      "diagnosis_mapping": "F33.1 - Recurrent Major Depressive Disorder, Moderate",
      "medications_reviewed": [
        "Sertraline (SSRI)"
      ],
      "match_status": "**MATCH** - *Sertraline* is a standard first-line treatment for *Major Depressive Disorder* (F33.1)."
    }
  },
  "duration_ms": 4966,
  "error": null
}